Ayoub Fares, Khalaf Mai, Devalaraju Samanthika Sahasra, Keihanian Tara, Skef Wasseem, Jawaid Salmaan, Othman Mohamed
Section of Gastroenterology, Hepatology and Nutrition.
Department of Medicine, Baylor College of Medicine, Houston, TX.
J Clin Gastroenterol. 2025 Jun 20. doi: 10.1097/MCG.0000000000002213.
Colorectal endoscopic submucosal dissection (ESD) is increasingly used for the management of laterally spreading colorectal lesions in the West. With increasing life expectancy and prevalence of colorectal neoplasia, ESD is frequently performed in the elderly. While ESD has been shown to be safe in elderly Eastern populations, there are key differences in endoscopist, patient, and lesion characteristics in the West. We investigated the safety and outcomes of colorectal ESD in a large Western cohort.
We retrospectively analyzed 710 colorectal lesions undergoing ESD at a tertiary medical center from July 2015 to November 2024. Patients were divided into 3 age groups: under 65 years (n=342), 65 to 75 years (n=272), and older than 75 years (n=96). Outcomes included en-bloc and R0 resection rates, procedural and postprocedural adverse events, and length of stay.
En-bloc resection rates (87.4%, 80.9%, and 80.2%) and R0 resection rates (69.6%, 68%, and 61.5%) were comparable across the <65, 65 to 75, and ≥75 groups, respectively. Despite higher comorbidities and use of antithrombotics/anticoagulants in the elderly group, overall postprocedure adverse event rates were low and with no significant difference among groups (6.7%, 8.5%, and 6.3%) (P=0.651). A higher length of stay in the ≥75 group was noted compared with the <65, 65 to 75, respectively (1.1 d, vs. 0.6 and 0.5, P<0.001).
Colorectal ESD in Western elderly patients by expert endoscopists is safe and effective, with outcomes comparable to younger cohorts. This study supports ESD as a feasible option for managing colorectal neoplasms in an aging population.
在西方,结直肠内镜黏膜下剥离术(ESD)越来越多地用于治疗结直肠侧向扩散性病变。随着预期寿命的延长和结直肠肿瘤患病率的增加,ESD在老年人中经常进行。虽然ESD在东方老年人群中已被证明是安全的,但西方在内镜医师、患者和病变特征方面存在关键差异。我们调查了一大群西方患者行结直肠ESD的安全性和结局。
我们回顾性分析了2015年7月至2024年11月在一家三级医疗中心接受ESD治疗的710例结直肠病变患者。患者分为3个年龄组:65岁以下(n = 342)、65至75岁(n = 272)和75岁以上(n = 96)。结局包括整块切除率和R0切除率、手术中和手术后的不良事件以及住院时间。
整块切除率(87.4%、80.9%和80.2%)和R0切除率(69.6%、68%和61.5%)在<65岁、65至75岁和≥75岁组中分别具有可比性。尽管老年组合并症更多且使用抗血栓/抗凝药物,但总体术后不良事件发生率较低,且各组之间无显著差异(6.7%、8.5%和6.3%)(P = 0.651)。与<65岁组和65至75岁组相比,≥75岁组的住院时间更长(分别为1.1天,而<65岁组和65至75岁组分别为0.6天和0.5天,P<0.001)。
由专业内镜医师对西方老年患者进行结直肠ESD是安全有效的,其结局与较年轻队列相当。本研究支持ESD作为老年人群中治疗结直肠肿瘤的一种可行选择。